Plasminogen activator inhibitor-1 can induce fibrinolysis abnormalities, which may lead to CVD via dysregulation of vascular clotting, endothelial dysfunction, and metabolic abnormalities1. The gene discussed is SERPINE1; the disease is endothelial dysfunction.